United European Gastroenterol J 2017 Aug 28;5(5):735-741. Epub 2016 Oct 28.
Gastroenterology Department, Edouard Herriot Hospital, Lyon, France.
Download full-text PDF
Colorectal Dis 2013 Dec;15(12):1489-92
Department of Colorectal Surgery, Sanford R. Weiss Center for Hereditary Colorectal Neoplasia, Digestive Diseases Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Aim: Intra-abdominal desmoid disease is one of the most common extra-intestinal manifestations of familial adenomatous polyposis. Small bowel obstruction occurs frequently in affected patients and is notoriously difficult to treat. The aim of this study was to review the management and outcome of desmoid-related small bowel obstruction. Read More
Arq Gastroenterol 2010 Oct-Dec;47(4):373-8
Context: Desmoid tumors constitute one of the most important extraintestinal manifestations of familial adenomatous polyposis. The development of desmoids is responsible for increasing morbidity and mortality rates in cases of familial adenomatous polyposis.
Objectives: To evaluate the occurrence of desmoid tumors in familial adenomatous polyposis cases following prophylactic colectomy and to present patient outcome. Read More
Br J Cancer 2011 Jan 9;104(1):37-42. Epub 2010 Nov 9.
The Netherlands Foundation for the Detection of Hereditary Tumours, Rijnsburgerweg 10, Poortgebouw Zuid, 2333 AA Leiden, The Netherlands.
Background: The optimal treatment of desmoid tumours is controversial. We evaluated desmoid management in Dutch familial adenomatous polyposis (FAP) patients.
Methods: Seventy-eight FAP patients with desmoids were identified from the Dutch Polyposis Registry. Read More
Fam Cancer 2018 Feb 27. Epub 2018 Feb 27.
Department of Urology, Northwick Park Hospital, Harrow, UK.
The aim of this retrospective cohort study was to review urological complication rates arising from familial adenomatous polyposis associated desmoid tumours and their management. All patients over a 35-year period were identified from a prospectively maintained polyposis registry database and had an intra-abdominal desmoid tumour. Those without ureteric complications (n = 118, group A) were compared to those that developed ureteric obstruction (n = 40, group B) for demographics, treatment interventions and survival outcomes. Read More